Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients

Table 2

Change in serum uric acid (UA) with allopurinol, benzbromarone, or both drugs.

Parameter	Allopurinol	Benzbromarone	Both drugs	𝑃
Age (years)	58.5±10	45.7±8.3	57.8±11.8	0.093
Urine UA (mg/day)	575±397	595.5±466	461.8±251.5	0.857
Pretreatment serum UA (mg/dL)	9±1.6	9.1±1	8.2±1.4	0.499
Posttreatment serum UA (mg/dL)	6.7±1.5	5.1±1.6	4.6±2.3	0.01*

∗Serum UA posttreatment with allopurinol versus serum UA posttreatment with benzbromarone or both drugs.